Stock-Based Compensation

$32.33M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$32.33Mperiod endingJun 30, 2026

NVAX Stock-Based Comp ($0.00 → $32.33M)

Annual stock-based compensation

High-resolution chart · PNG

NVAX stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	36,015,000
Dec 31, 2024	48,152,000
Dec 31, 2023	85,357,000
Dec 31, 2022	130,300,000
Dec 31, 2021	183,626,000
Dec 31, 2020	128,035,000
Dec 31, 2019	17,048,000
Dec 31, 2018	18,314,000
Dec 31, 2017	19,809,000
Dec 31, 2016	19,160,000
Dec 31, 2015	13,431,000
Dec 31, 2014	6,090,000
Dec 31, 2013	2,480,000
Dec 31, 2012	2,091,000
Dec 31, 2011	2,047,000
Dec 31, 2010	1,339,000
Dec 31, 2009	1,533,000
Dec 31, 2008	2,070,000
Dec 31, 2007	1,800,000
Dec 31, 2006	2,267,000
Dec 31, 2005	406,000
Dec 31, 2004	53,000
Dec 31, 2003	0
Dec 31, 2002	108,000
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0